Correlation Between TG Therapeutics and Obayashi
Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and Obayashi at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and Obayashi into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TG Therapeutics and Obayashi, you can compare the effects of market volatilities on TG Therapeutics and Obayashi and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of Obayashi. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and Obayashi.
Diversification Opportunities for TG Therapeutics and Obayashi
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between TGTX and Obayashi is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and Obayashi in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Obayashi and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with Obayashi. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Obayashi has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and Obayashi go up and down completely randomly.
Pair Corralation between TG Therapeutics and Obayashi
Given the investment horizon of 90 days TG Therapeutics is expected to generate 1.57 times more return on investment than Obayashi. However, TG Therapeutics is 1.57 times more volatile than Obayashi. It trades about 0.15 of its potential returns per unit of risk. Obayashi is currently generating about 0.13 per unit of risk. If you would invest 2,506 in TG Therapeutics on October 1, 2024 and sell it today you would earn a total of 747.00 from holding TG Therapeutics or generate 29.81% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 97.67% |
Values | Daily Returns |
TG Therapeutics vs. Obayashi
Performance |
Timeline |
TG Therapeutics |
Obayashi |
TG Therapeutics and Obayashi Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with TG Therapeutics and Obayashi
The main advantage of trading using opposite TG Therapeutics and Obayashi positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, Obayashi can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Obayashi will offset losses from the drop in Obayashi's long position.TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Obayashi vs. Watsco Inc | Obayashi vs. Fastenal Company | Obayashi vs. SiteOne Landscape Supply | Obayashi vs. Ferguson Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |